Journal Menu
► ▼ Journal Menu-
- Medicina Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
2 July 2025
MDPI INSIGHTS: The CEO's Letter #24 - 2024 Impact Factor & CiteScore, MDPI Summits France & USA, Tu Youyou Award
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI’s 2024 Impact Factor Highlights
For those of our readers who are new to academic publishing, you may have heard some news in June around the Impact Factor release. Every year, typically in June, Clarivate releases its annual Journal Citation Reports (JCR), which include Journal Impact Factors (JIF). This metric is widely used in academic publishing to reflect the average number of citations received by recent articles in each journal.
While Impact Factor is just one of many indicators of journal influence, it remains a major milestone for authors, editors, and publishers. It’s used to assess journal visibility, researcher recognition, and scholarly reach. Throughout our international meetings and events, it’s clear that the Impact Factor is something many of our authors and editorial board members care about, as it can influence where they choose to submit an article and the funding they receive for their research.
“These results reflect the trust that the scholarly community places in MDPI”
MDPI’s 2024 Impact Factor Highlights
- 298 MDPI journals received a Journal Impact Factor.
- 60 journals earned their first-ever Impact Factor
- To put this in perspective: MDPI’s 60 new journal acceptances into the Web of Science was the second highest number of any publisher in 2024, behind Elsevier and ahead of Springer Nature. Our 87% acceptance rate for journals submitted to Web of Science shows the strength of our editorial process and our proven ability to develop journals aligned with Clarivate’s 24 evaluation criteria.
- Notably, Textiles, Mathematics, International Journal of Neonatal Screening, Smart Cities, Systems, and Pharmaceutics ranked in the top 10% in their respective categories, highlighting their growing influence and prestige within their academic fields. This shows that high-quality indexing goes beyond visibility; it upholds credibility and trust.
- 193 MDPI journals are now ranked in the top 50% (Q1/Q2) of their subject categories.
- What does this mean, and why is it important? Journals are ranked by quartiles within their field, based on their Impact Factor. Q1 represents the top 25% of journals in their category, Q2 the next 25%, and so on. Being in Q1 or Q2 shows that a journal is performing well relative to other journals in its category. Authors and institutions often look at quartile rankings when choosing where to publish – it’s an important indicator of visibility and recognition, within its respective category.
- 116 of our previously ranked journals increased their Impact Factor.
- 14 MDPI journals achieved an Impact Factor of 5.0 or higher, suggesting a high degree of influence and visibility.
These results reflect our staff's hard work: from our editorial and production teams to our indexing, communications, and data teams, and beyond. This also reflects the trust that the scholarly community places in MDPI, reinforcing the message that when researchers publish with MDPI, they publish with impact.
Open Access with Impact
As the leading fully open access publisher, our journals have received a total of 18.4 million citations in the Web of Science by the end of 2024, reflecting the growing reach and engagement of research published with MDPI. We are committed to making scientific research freely accessible to everyone, everywhere. With the support of more than 4.2 million contributing authors, we’re proud to support the global shift toward open access.
Further Reading
If you’d like to better understand how journals get indexed and why Impact Factors matter, please read this recent interview with Dr. Constanze Schelhorn (Head of Indexing). It gives you a behind-the-scenes look at the role our indexing team plays in supporting journal indexing and visibility.
You can also read our official news announcement shared last week: MDPI Journals in the 2024 Journal Citation Reports.
Thank you to everyone, from our authors and reviewers to our editors and internal teams, who contributed to the progress of our journal indexing in 2024. We’re continuing to build journals that are recognized and trusted across disciplines.
Impactful Research

MDPI Journals See Continued Growth in 2024 CiteScore Results
Continuing our indexing updates, I’m pleased to share that MDPI has achieved strong results in the latest CiteScore metrics, released on 5 June by Scopus. These results reflect the collective efforts of our editors, reviewers, authors, and internal teams, with their dedication to quality and visibility in scientific publishing. You can read the full announcement here.
2024 Highlights:
- 322 MDPI journals received a CiteScore (up from 274 last year).
- 283 journals (88%) are ranked in Q1 or Q2 of their subject categories.
- 237 journals (85%) saw an increase in their CiteScore compared to last year.
- 48 journals received a CiteScore for the first time.
- 39 journals are now placed in the top 10% of their subject areas.
“This growth highlights our commitment to supporting open, trusted science”
What is CiteScore and how is it measured?
CiteScore metrics are developed by Elsevier as an alternative to the Impact Factor. They measure the citation impact of journals and can be accessed freely on Scopus. The metric represents the yearly average number of citations to recent articles published in a journal. If you’re interested in learning more about citation metrics and how we use them, check out this blog post.
Why is this important?
These results show the growing recognition for, and impact of, MDPI journals across disciplines. CiteScore rankings help researchers, institutions, and funders assess where high-quality work is being published. This growth improves our journals’ positioning in the publishing landscape and highlights our commitment to supporting open, trusted science.
Inside MDPI

Highlights from the MDPI USA Summit in Boston (5–6 June)
With several Summits already behind us, I think this is a good time to reflect on the purpose of these Summits.
Why do we organize MDPI Summits?
These one-and-a-half-day, invite-only gatherings are designed to improve our relationships with Chief Editors who lead our journals and are respected voices in their fields. The Summits aim to:
- Share MDPI’s values, achievements, editorial practices, and local market collaborations.
- Collect feedback on MDPI operations and journal practices.
- Empower Chief Editors to confidently represent MDPI beyond the Summit.
While Chief Editors know their journals well, these events help them better understand MDPI. We want them to be ambassadors for our brand. The aim is for them to walk away informed, engaged, and equipped to share positively about MDPI.
|
|
|
|
About the Boston Summit
Held on 5–6 June, our first USA Summit gathered over 25 Chief Editors to learn more about MDPI’s activities and collaborations in the USA. The program included presentations, Q&A, and a panel discussion.
Agenda Highlights:
Moderated by Summer Huggard (Operations Manager [Toronto], MDPI), the program featured:
- MDPI Overview and USA Collaboration – Stefan Tochev (CEO, MDPI)
- AI in Publishing and MDPI's Actions – Feichi Lu (Junior Data Scientist, MDPI)
- MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
- Panel Discussion – Stefan, Feichi, Giulia, Claudia
- Society Partnerships – Dr. Clàudia Aunós (Society Partnerships Senior Manager, MDPI)
- Voice of the Customer and Closing Remarks – Stefan Tochev (CEO, MDPI)
|
|
|
|
|
|
|
|
MDPI & the USA: Facts and Figures
- With over 216,000 publications, the USA is MDPI’s second-largest contributor after China.
- In 2024, the USA ranked 2nd in total submissions and 2nd in total MDPI publications, with more than 28,200 publications.
- As of 2020, the cumulative number of authors from the USA until April 2025 was 352,099.
- As at April 2025, there are more than 12,035 active Editorial Board Members (EBMs) from the USA, with 55% having an H-index over 26.
- Among them, 96 serve as Editors-in-Chief (EiC) and 218 as section-Editors-in-Chief (SEiC)
- MDPI has more than 920 Institutional Open Access Program agreements worldwide, with over 130 from the USA.

A special thanks to our Toronto team, and everyone who worked behind the scenes to make this event run smoothly.
Coming Together for Science

Highlights from the MDPI France Summit in Paris (12–13 June)
We completed our first MDPI France Summit in Paris last week, and it was a special event. Attendees were engaged from beginning to end, remaining after hours to network and collaborate.
|
|
|
|
Why a France Summit?
We chose to host a France Summit in view of the recent challenges MDPI has faced with the National Centre for Scientific Research (CNRS). What we took away from the event is that our authors and editors very much appreciate and enjoy working with us, but we need to address the concerns raised by CNRS, around Article Processing Charges (APCs) and the funding of gold open access publications.
“Our authors and editors very much enjoy working with us”
Some of the claims made in the June 2023 interview with Alain Schuhl, the Deputy CEO for Science at the CNRS, are simply not factual. For example, they state that MDPI’s “average APC charges per article are now around the same as Springer Nature’s.” Here is the relevant passage, reproduced verbatim:

This is not accurate.
A recent preprint analysing APC data from Elsevier, Springer Nature, Wiley, PLOS, MDPI, and Frontiers (2019–2023) shows that MDPI’s average APCs remain significantly lower than those of Springer Nature and several other major publishers.


The MDPI Summits are part of our outreach and communication efforts to address misconceptions and clarify MDPI’s position as one of the most accessible and affordable major gold open access publishers in the world.
Summit Overview
Held on 12–13 June, the France Summit gathered over 20 Chief Editors to learn more about MDPI’s activities and collaborations in France. Many of these editors are influential in their institutions and professional societies. Several also have connections to CNRS, which makes this an important opportunity to clarify how we operate and build trust through open and transparent communication and hopefully turn our editors into informed advocates of MDPI.
Summit Feedback
The feedback has been very positive, with most attendees completing the post-event survey and all rating the experience as Excellent or Good. A few highlights:
- “The whole thing was highly professional and, above all, provided quantified details that will allow us to better answer questions surrounding MDPI.”
- “The summit was an opportunity to meet personally various people directly engaged in the organization and policies of MDPI, which made it possible to clarify some important points concerning publishing with MDPI.”
- “Very well organized! A great opportunity to see all French MDPI partners and editors.”
Program Highlights:
Moderated by Miruna Adelina Nicolcioiu (Senior Conference Producer), the program featured:
- MDPI Overview and France Collaboration – Stefan Tochev (CEO)
- MDPI Editorial Process and Peer-Review Quality – Dr. Marta Colomer (Public Affairs Specialist)
- Institutional Partnerships and Open Access Funding Models – Becky Castellon (Institutional Partnerships Manager)
- AI in Publishing and MDPI's Actions – Daniele Raimondi (Data Scientist)
- Publication Ethics: Global Trends – Diana Cristina Apodaritei (Research Integrity Specialist)
- Closing Remarks – Stefan Tochev
- Panel Discussion – Diana, Becky, Prof. Dr. Patrick Da Cost, and Stefan
|
|
|
|
|
|
|
|
MDPI & France: Facts and Figures
- With over 51,000 publications, France is MDPI's tenth-largest contributor, and fifth largest among EU countries after Italy, Spain, Germany, and Poland.
- As of 2020, the cumulative number of authors from France until April 2025 was 87,592.
- As at April 2025, there are more than 2,800 active Editorial Board Members (EBMs) from France, with 59% having an H-index over 26.
- Among them, 22 serve as Editors-in-Chief (EiC) and 61 as section-Editors-in-Chief (SEiC)
- In 2024, IJMS, JCM, and Molecules were the top three MDPI journals in terms of submissions from French-affiliated authors.

Special thanks to our colleagues from Romanian offices for organizing this successful event.
Closing Thoughts

Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award
As we wrap up this month’s newsletter, I’d like to take a moment to recognize the winners of the 2024 Tu Youyou Award, presented by our journal Molecules. I am pleased to share that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.
I invite you to read the editorial co-authored by the Tu Youyou Award Committee, which highlights the significance of the award and the remarkable impact of the recipients’ research.
A sincere thank-you to the 2024 Award Committee for their dedication and selection process, and congratulations once again to this year’s honourees. Your work exemplifies the kind of research MDPI is proud to support and amplify.
|
About the Tu Youyou Award For further information about the award and the winners, please visit the Tu Youyou Award website. |
Chief Executive Officer
MDPI AG
6 June 2025
Medicina | Highly Cited Papers in 2024 and Hot Topic Special Issues in the “Obstetrics and Gynecology” Section
We would like to share with you some highly cited papers from the Section “Obstetrics and Gynecology” that were published in Medicina (ISSN: 1648-9144) in 2024, which you are welcome to read. You can also find the journal’s latest publications via the following website: https://www.mdpi.com/search?journal=medicina§ion=752.
Additionally, some Special Issues in the “Obstetrics and Gynecology” Section are currently open for submission. The following is a list of articles and Special Issues that we believe may interest you:
1. “Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review”
by Antonio D’Amato, Gaetano Riemma, Vittorio Agrifoglio, Vito Chiantera, Antonio Simone Laganà, Mislav Mikuš, Miriam Dellino, Annamaria Maglione, Raffaele Faioli, Andrea Giannini et al.
Medicina 2024, 60(4), 608; https://doi.org/10.3390/medicina60040608
Available online: https://www.mdpi.com/1648-9144/60/4/608
2. “Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases”
by Rafał Watrowski, Mario Palumbo, Serena Guerra, Alessandra Gallo, Brunella Zizolfi, Pierluigi Giampaolino, Giuseppe Bifulco, Attilio Di Spiezio Sardo and Maria Chiara De Angelis
Medicina 2024, 60(1), 179; https://doi.org/10.3390/medicina60010179
Available online: https://www.mdpi.com/1648-9144/60/1/179
3. “MicroRNA Expression in Endometrial Cancer: Current Knowledge and Therapeutic Implications”
by Irene Iavarone, Rossella Molitierno, Pietro Fumiento, Maria Giovanna Vastarella, Stefania Napolitano, Maria Teresa Vietri, Pasquale De Franciscis and Carlo Ronsini
Medicina 2024, 60(3), 486; https://doi.org/10.3390/medicina60030486
Available online: https://www.mdpi.com/1648-9144/60/3/486
4. “Ovarian Cancer and the Microbiome: Connecting the Dots for Early Diagnosis and Therapeutic Innovations—A Review”
by Seo-Yoon Choi and Jung-Hye Choi
Medicina 2024, 60(3), 516; https://doi.org/10.3390/medicina60030516
Available online: https://www.mdpi.com/1648-9144/60/3/516
5. “Fresh versus Frozen Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Systematic Review and Meta-Analysis of Neonatal Outcomes”
by Raluca Tocariu, Lucia Elena Niculae, Alexandru Ștefan Niculae, Andreea Carp-Velișcu and Elvira Brătilă
Medicina 2024, 60(8), 1373; https://doi.org/10.3390/medicina60081373
Available online: https://www.mdpi.com/1648-9144/60/8/1373
6. “Correlation between Overweight, Obesity, Gestational Diabetes Mellitus, Adipokines (Adipolin and Adiponectin), and Adverse Pregnancy Outcomes: A Pilot Study”
by Muntean Mihai, Săsăran Vladut, Luca Sonia-Teodora, Suciu Laura Mihaela, Nyulas Victoria, Muntean Irina Elena and Mărginean Claudiu
Medicina 2024, 60(9), 1544; https://doi.org/10.3390/medicina60091544
Available online: https://www.mdpi.com/1648-9144/60/9/1544
7. “Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome”
by Márió Vincze, János Sikovanyecz Jr., András Molnár, Imre Földesi, Andrea Surányi, Szabolcs Várbíró, Gábor Németh, János Sikovanyecz and Zoltan Kozinszky
Medicina 2024, 60(1), 85; https://doi.org/10.3390/medicina60010085
Available online: https://www.mdpi.com/1648-9144/60/1/85
8. “Cornual Pregnancy: Results of a Single-Center Retrospective Experience and Systematic Review on Reproductive Outcomes”
by Fathi Mraihi, Giovanni Buzzaccarini, Antonio D’Amato, Antonio Simone Laganà, Jihene Basly, Chaima Mejri, Montasar Hafsi, Dalenda Chelli, Zaineb Ghali, Bianca Bianco et al.
Medicina 2024, 60(1), 186; https://doi.org/10.3390/medicina60010186
Available online: https://www.mdpi.com/1648-9144/60/1/186
9. “Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss”
by Ema Borsi, Ovidiu Potre, Ioana Ionita, Miruna Samfireag, Cristina Secosan and Cristina Potre
Medicina 2024, 60(4), 521; https://doi.org/10.3390/medicina60040521
Available online: https://www.mdpi.com/1648-9144/60/4/521
10. “Dietary Supplementation of Myo-Inositol, Cocoa Polyphenols, and Soy Isoflavones Improves Vasomotor Symptoms and Metabolic Profile in Menopausal Women with Metabolic Syndrome: A Retrospective Clinical Study”
by Giampaolo Mainini, Salvatore Ercolano, Raffaella De Simone, Irene Iavarone, Rosalia Lizza and Mario Passaro
Medicina 2024, 60(4), 598; https://doi.org/10.3390/medicina60040598
Available online: https://www.mdpi.com/1648-9144/60/4/598
Special Issues:
“New Insights into Gynecological Disease”
Guest Editors: Dr. Gaspare Cucinella and Dr. Valentina Billone
Submission deadline: 15 November 2025
“Adenomyosis and Endometriosis-Related Infertility”
Guest Editors: Prof. Dr. Simone Ferrero and Dr. Giuseppe Gullo
Submission deadline: 20 November 2025
“Gynecological and Oncological Diseases in the Aged”
Guest Editors: Prof. Dr. Stefan Sajdak, Dr. Monika Englert-Golon and Dr. Katarzyna Plagens-Rotman
Submission deadline: 30 November 2025
“Advances in Cervical Cancer Treatment and HPV Management: From Conventional Therapies to Emerging Strategies”
Guest Editors: Dr. Mariano Catello Di Donna and Dr. Maria Cristina Solazzo
Submission deadline: 20 December 2025
6 June 2025
Medicina | Special Issue Reprints Published in the First Half of 2025
We are pleased to share with you reprints of Special Issues published in the first half of 2025 in Medicina (ISSN: 1648-9144). To read more reprints, please visit the following website: https://www.mdpi.com/books/search.

Edited by Romica Cergan, Adrian Costache and Mihai Dumitru
ISBN 978-3-7258-2729-9 (Hardback)
ISBN 978-3-7258-2730-5 (PDF)
https://doi.org/10.3390/books978-3-7258-2730-5
Available online: https://www.mdpi.com/books/reprint/10283-diagnostic-and-interventional-imaging-in-various-diseases

Edited by Julian Schmoeckel
ISBN 978-3-7258-3407-5 (Hardback)
SBN 978-3-7258-3408-2 (PDF)
https://doi.org/10.3390/books978-3-7258-3408-2
Available online: https://www.mdpi.com/books/reprint/10603-updates-on-caries-management-in-the-primary-and-permanent-dentition

Edited by Yuzuru Ohshiro, Kunimasa Yagi and Yasuhiro Maeno
ISBN 978-3-7258-3830-1 (Hardback)
ISBN 978-3-7258-3829-5 (PDF)
https://doi.org/10.3390/books978-3-7258-3829-5
Available online: https://www.mdpi.com/books/reprint/10785-advances-in-clinical-diabetes-obesity-and-metabolic-diseases
4 June 2025
Meet Us Virtually at the 1st International Online Conference on Healthcare—The Future of Healthcare: Innovations and Trends, 25–26 March 2026
Conference: The 1st International Online Conference on Healthcare—The Future of Healthcare: Innovations and Trends
Date: 25–26 March 2026
Conference webpage: https://sciforum.net/event/IOCH2026
You are invited to join this virtual event organized by MDPI’s Healthcare (ISSN: 2227-9032; Impact Factor: 2.4), taking place from 25 to 26 March 2026.
Conference Chair: Prof. Dr. Lorraine S. Evangelista, University of California Irvine, California, USA.
The Topics of Interest:
S1. Digital Health Adoption and Innovation: A Vision for the Future of Healthcare;
S2. Patient-Centered Care—Optimizing Care Pathways through Engagement and Outcome Measurement;
S3. Connected Care—Leveraging Technology to Build an Integrated Care Ecosystem;
S4. Clinical Data Management—Balancing Transparency with Innovation for Enhanced Care Quality;
S5. Generative AI in Clinical Practice—Evidence-Based Evaluation of Diagnostic and Therapeutic Applications.
Important Dates:
Deadline for abstract submission: 26 November 2025;
Notification of acceptance: 26 December 2025;
Deadline for registration: 20 March 2026.
Submit your abstract here.
Register for the conference here.
For any inquiries regarding the event, please contact ioch2026@mdpi.com.
We look forward to seeing you at IOCH2026.
3 June 2025
MDPI INSIGHTS: The CEO's Letter #23 - MDPI Summits Spain & Italy, Ei Compendex, and Editorial Independence
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

Highlights from the MDPI Spain Summit in Barcelona (21-22 May)
In May we hosted the MDPI Spain Summit in Barcelona – our second summit in the city following the inaugural one in November 2023.

Stefan Tochev (CEO, MDPI) at the MDPI Spain Summit in Barcelona, 22 May 2025.
Creating a space for exchange of views
The goal of our summits is to bring together Chief Editors of MDPI journals from across disciplines and institutions. These intimate gatherings provide a platform to present the latest developments at MDPI and to initiate open conversations about our journals, the future of open access, and the evolving landscape of scientific publishing.
Most importantly, these are opportunities for in-person connection, providing a more meaningful space for the exchange of views and for building long-term relationships.
Exploring the future of scientific publishing in Spain
The summit took place on 21–22 May and featured a mix of MDPI presentations (including two guest presentations), roundtable discussions, and Q&A sessions. On the first day, we held a focused session with our Chief Editors to gather feedback and have open discussions on their journal development, the peer-review process, and local accreditation systems.

Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI, presents MDPI’s Editorial Process and Peer Review Quality Metrics at the MDPI Spain Summit in Barcelona, 22 May 2025.
I had the pleasure of opening the Summit with a welcome address and an overview of MDPI’s recent milestones. The agenda then included the following sessions:
- MDPI and Recent Developments in the Spanish Market – Dr. Marta Colomer (Public Affairs Specialist, MDPI)
- MDPI Editorial Process and Peer Review Quality Metrics – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
- Open Access in Spain – Dr. Remedios Melero (Researcher, CSIC – guest speaker)
- AI in Publishing and MDPI's Actions – Dr. Enric Sayas (Business Analyst, MDPI), Daniele Raimondi (Data Scientist, MDPI), and Dr. Alexandre López-Borrull (Researcher, Universitat Oberta de Catalunya – guest speaker)
- Publication Ethics – Ana Stankovic (Research Integrity and Publication Ethics, MDPI)
- Opening and Closing remarks were provided by Rocksy Zhang (Editorial Director, MDPI)
We are extremely grateful for the strong engagement shown by our Editors, who were clearly appreciative of the event and the discussions we had. They felt seen and heard, which is a vital prerequisite for building open channels of communication and cultivating productive long-term collaborations.

MDPI colleagues during MDPI Spain Summit in Barcelona (22 May 2025).
A big thank-you to the entire Barcelona team for organizing such a successful event!
Upcoming MDPI Summit events:
- Italy Summit – Rome (26–27 May)
- US Summit – Boston, MA (5–6 June)
- France Summit – Paris (12–13 June)
- US Summit – Houston, TX (26–27 June)
- UK Summit – London (16–17 September)
- Germany Summit – Berlin (18–19 September)
- Romania Summit – Bucharest (23–24 October)
...with more in between, and more to follow.
Impactful Research

50 MDPI Journals Now Indexed in Ei Compendex
Indexing is a key indicator of a journal’s scientific impact. An indexed journal gives research greater visibility and credibility within the global academic community and is recognized for its quality and relevance. While many of our journals are included in major databases such as Web of Science and Scopus, MDPI also places strong emphasis on journal inclusion in subject-specific indexing platforms that align with each journal’s scope. This ensures that when you publish with MDPI, you publish with impact.
I’m pleased to share that as at May 2025, 51 of our journals are now indexed in Ei Compendex, a leading bibliographic database for engineering and applied sciences. This is a major milestone that reflects both the quality or our editorial processes and the relevance of the research we publish in these fields.
“When you publish with MDPI, you publish with impact”
Discoverability and reach
Inclusion in Ei Compendex means greater discoverability for our authors and broader reach of our journals in the fields of engineering and technology. It improves our ability to support global research and innovation, while building MDPI’s reputation in the applied sciences. This recognition is the result of the dedicated work of our editorial teams, reviewers, and authors, and of our overall commitment to excellence in publishing.
You can read our full announcement here.
Appreciative thanks to everyone involved in reaching this milestone.
Inside MDPI
One Year of MDPI’s Seoul Office
On 29 April, we marked one year since the opening of our Seoul office, MDPI’s first local hub in South Korea. South Korea is a key market for MDPI, currently ranking as our sixth-largest contributor to the company’s total publications, with over 89,000 MDPI articles authored by individuals affiliated with Korean institutions. Over the past 12 months, the Seoul team has made great strides in building our visibility, networks, and presence in the region.
A few highlights from the past year

Claude Seo (MDPI Korea Office Manager, Seoul)
Claude Seo, who has over 15 years of experience in the academic publishing industry, is the Office Manager of the Seoul office.
In its inaugural year, the Seoul office focused primarily on marketing and promotional activities to support the MDPI brand locally. During that time, the team concentrated on scholar visits to local institutions, attending academic conferences, and hosting editorial board meetings.
The team also secured 10 Institutional Open Access Program (IOAP) renewals, signed three new IOAP agreements, and established one new Society affiliation.
The Seoul office also hosted its first library book fair and reached over 1,000 followers on its LinkedIn channel, which is an encouraging indication of local visibility and engagement.
“The Seoul team has made strides in building our visibility, networks, and presence in the region”
Growth plans
Later this year, we are working on opening a new Seoul office in a more central location, with room for our growing team. The new space will bring us closer to other publishing partners and provide easier access to and from the airport. The Seoul office will continue to expand its efforts in outreach and engagement as its builds its presence in South Korea.
Warm thanks to the entire Seoul team for their hard work and dedication, and to all MDPI colleagues who have contributed to this exciting chapter in our global journey.
Coming Together for Science

Highlights from the MDPI Italy Summit in Rome (26–27 May)
We closed the month of May by hosting the first MDPI Italy Summit in Rome. This was an important event for us, as Italy has consistently ranked among the top ten countries globally for open access publications over the past decade.
MDPI and Italy: Facts & Figures
- With over 144,000 publications (as at 31 May 2025), Italy is MDPI’s third largest contributor after China and the USA.
- In 2024, MDPI was the second-largest publishing house in Italy.
- The 7,165 Editorial Board Members (EBMs) drawn from Italian institutions represent 8.9% of all MDPI academic editors.
- Among these, 319 serve as Editors-in-Chief (EiCs) or Section Editors-in-Chief (SEiCs).
- Eleven Italian EBMs were recognized as 2024 Clarivate Highly Cited Researchers.
- In 2024, MDPI received 24,873 review reports and collaborated with 88,578 reviewers from Italy.
- 23,131 Guest Editors from Italian institutions led 4,827 Special Issues across 248 MDPI journals.
- MDPI partners with over 900 institutions globally, of which 17 are in Italy.
The MDPI Italy Summit in Rome

Dr. Prof. Giulio Cerullo, EiC of Applied Sciences, at the MDPI Italy Summit in Rome (27 May 2025).
Held on 26–27 May, the MDPI Italy Summit brought together 25 Chief Editors from across our journal portfolio, including some of our largest journals such as Applied Sciences, to discuss MDPI’s latest developments and collaborations in the Italian market, our use of data intelligence and AI to support strategic decision-making, a look into our editorial process, peer-review quality metrics, and conversations around research integrity and community engagement.
The Summit featured MDPI presentations followed by Q&A and concluded with a roundtable discussion. On the evening of the 26th, we hosted a dinner with our Editors to connect personally, learn more about their research, and hear feedback on journal operations and the broader academic landscape in Italy.

Gathering of Editors-in-Chief and MDPI staff at the MDPI Italy Summit in Rome (27 May 2025).
Event Agenda – 27 May
Moderated by Maddalena Favaretto (Conference Scientific Advisor, MDPI), the program featured:
- MDPI Overview, Achievements, Latest News and Future Developments – Stefan Tochev (CEO, MDPI)
- Country Report: Italy – Dr. Laura Perez Martin (Conference Assistant, MDPI)
- AI in Publishing and MDPI’s Actions – Dr. Andrea Perlato (Head of Data Analytics, MDPI)
- MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
- Panel Discussion – Stefan, Andrea, Giulia

Panel Discussion with Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI), Dr. Andrea Perlato (Head of Data Analytics, MDPI) during the MDPI Italy Summit in Rome (27 May 2025).
A big thank-you to our Conference team and everyone who worked behind the scenes to make these events run smoothly.
Closing Thoughts

Upholding Editorial Independence in Scholarly Publishing
A recent MDPI blog post written by Dr. Ioana Craciun (Scientific Communications Specialist, MDPI), “Editorial Independence and Publisher Support: Collaborating to Uphold Integrity,” highlights the important balance between editorial autonomy and publisher collaboration in academic publishing.
As the leading fully Open Access scholarly publisher, we are proud to champion editorial independence within our publishing process.
Drawing from the Committee on Publication Ethics (COPE) guidelines, the article emphasizes that while editors must have the freedom to make decisions based on scholarly merit, publishers play a critical role in providing the necessary infrastructure and tools to support the editorial process. This collaborative approach ensures the integrity of the peer review process, builds trust among authors and readers, and upholds the quality and relevance of published content.
MDPI highlights its commitment to this model by investing in research integrity specialists, AI tools for plagiarism detection, and administrative support, all aimed at empowering editors to make independent, informed decisions.
Chief Executive Officer
MDPI AG
20 May 2025
Meet Us at the ESC Congress 2025, 29 August–1 September 2025, Madrid, Spain
Conference: ESC Congress 2025
Date: 29 August–1 September 2025
Location: Madrid, Spain
We will be attending the ESC Congress 2025 together with the World Congress of Cardiology as an exhibitor. The event will take place in Madrid, Spain, from 29 August to 1 September 2025.
Organized by the European Society of Cardiology, the ESC Congress 2025 will focus on the theme “Cardiology Beyond Borders – Global Health”, highlighting the evolving role of cardiovascular disease within the broader global health landscape.
The following Open Access journals will be represented:
- JCM;
- JCDD;
- Healthcare;
- Biomedicines;
- Cardiogenetics;
- IJTM;
- Hearts;
- Medicina;
- IJERPH;
- Diseases;
- Genes;
- EJIHPE;
- JPM;
- Clinics and Practice;
- Tomography.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #B206 and answering any questions you may have. For more information about the conference, please visit the following website: https://www.escardio.org/Congresses-Events/ESC-Congress.
13 May 2025
Empowering Academic Growth with MDPI: A Scientific Publishing Exchange at Toronto Metropolitan University, 15 May 2025
MDPI is excited to collaborate with Toronto Metropolitan University to host an engaging Scientific Publishing Workshop aimed at empowering scholars with the knowledge and tools needed to succeed in academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving their scientific writing and effectively addressing reviewer comments, with guidance from an experienced professional. This session promises to equip attendees with valuable skills to elevate their publishing journey.
Workshop Highlights:
- Learn How to Better Write and Structure a Research Article;
- How to Choose Where to Publish Academic Work;
- How to Respond to Reviewer Comments;
- Reasons for Rejection During Pre-Check;
- How to Navigate Through Ethics and AI Use.
Date: 15 May 2025
Time: 12:00–1:30 p.m.
Venue: Toronto Metropolitan University
Program:
|
Speakers |
Program and Content |
Time |
|
Dr. Stephen Mora |
Introduction to MDPI |
12:00–12:05 p.m. |
|
|
How to Write and Structure a Research Article |
12:05–12:45 p.m. |
|
|
How to Respond to Reviewer Comments |
12:45–1:30 p.m. |

11 May 2025
Medicina Webinar | Challenges in the Clinical Practice of Multiple Sclerosis, 20 May 2025
Women are up to three times more likely than males to develop multiple sclerosis (MS), a chronic immune-mediated, inflammatory, and degenerative disease of the central nervous system. It was recommended that women with multiple sclerosis refrain from getting pregnant around fifty years ago. Since then, epidemiological studies have provided evidence that pregnancies have no effect on the course of the disease and that a mother’s MS condition has no detrimental effects on the development of her child. For women with MS, there are other unknowns to take into account, such as the possibility that their capacity to care for their children may be impacted by acute relapses and incapacity in the future. MS immunotherapies and medical knowledge about pregnancy and fertility are always changing, so treatment recommendations in this field should be updated on a regular basis. A multidisciplinary approach to treating MS is essential since, crucially, the longevity of individuals with MS is growing. Cardiovascular diseases (CVDs) may be linked to MS; however, this connection has received little attention. Additionally, MS patients are more likely to experience cardiovascular risk factors. However, diseases such as Takotsubo syndrome are uncommon side effects of multiple sclerosis. It is also intriguing how myocarditis and MS are similar. Lastly, heart toxicity is a common side effect of MS medications. This webinar's objective is to present an update on pregnancy-related concerns for women with MS, including suggestions for counseling; general care; the use of DMTs before, during, and after pregnancy; and DMTs' effects on nursing. To stimulate more clinical and pre-clinical research on the subject, the second section of this webinar will give an overview of cardiovascular problems in MS and their management.
Date: 20 May 2025
Time: 6:00 p.m. CEST | 7:00 p.m. EEDT
Webinar ID: 827 6230 9752
Program:
|
Speaker/Presentation |
Time in CEST |
Time in EEDT |
|
Dr. Anastasia Bougea |
6:00–6:10 p.m. |
7:00–7:10 p.m. |
|
Dr. Gabriela Mihăilescu |
6:10–6:30 p.m. |
7:10–7:30 p.m. |
|
Dr. Elias Gialafos |
6:30–6:50 p.m. |
7:30–7:50 p.m. |
|
Q&A Session |
6:50–7:10 p.m. |
7:50–8:10 p.m. |
|
Dr. Anastasia Bougea |
7:10–7:15 p.m. |
8:10–8:15 p.m. |
After registering, you will receive a confirmation email with information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
If you are unable to attend, register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Invited Speakers:
- Dr. Anastasia Bougea (Chair), Department of Neurology, National and Kapodistrian University of Athens, Athens, Greece;
- Dr. Gabriela Mihăilescu, Neurologie, Bucharest, Romania;
- Dr. Elias Gialafos, Department of Neurology, National and Kapodistrian University of Athens, Athens, Greece.
For more information about this webinar, please visit the following link: https://sciforum.net/event/Medicina-5.
If you have any questions about the webinar, please contact medicina@mdpi.com.
Medicina Webinar Secretariat
8 May 2025
Medicina | Highly Cited Papers in 2024 and Hot Topic Special Issues in the Section “Cardiology”
We are delighted to share some highly cited papers from the Section “Cardiology” that were published in Medicina (ISSN: 1648-9144) in 2024. You are welcome to read these highly cited papers and find the latest publications through the following link: https://www.mdpi.com/search?journal=medicina§ion=1116. Additionally, some Special Issues in the “Cardiology” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:
1. “Inherited Arrhythmias in the Pediatric Population: An Updated Overview”
by Marco Valerio Mariani, Nicola Pierucci, Francesca Fanisio, Domenico Laviola, Giacomo Silvetti, Agostino Piro, Vincenzo Mirco La Fazia, Cristina Chimenti, Marco Rebecchi, Fabrizio Drago et al.
Medicina 2024, 60(1), 94; https://doi.org/10.3390/medicina60010094
Available online: https://www.mdpi.com/1648-9144/60/1/94
2. “A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists”
by En-Hao Hu, Ming-Lung Tsai, Yuan Lin, Tien-Shin Chou and Tien-Hsing Chen
Medicina 2024, 60(3), 357; https://doi.org/10.3390/medicina60030357
Available online: https://www.mdpi.com/1648-9144/60/3/357
3. “The Role of Gut Microbiota and the Potential Effects of Probiotics in Heart Failure”
by Carmine Petruzziello, Angela Saviano, Luca Luigi Manetti, Noemi Macerola and Veronica Ojetti
Medicina 2024, 60(2), 271; https://doi.org/10.3390/medicina60020271
Available online: https://www.mdpi.com/1648-9144/60/2/271
4. “The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure”
by Karolina Wróbel-Nowicka, Celina Wojciechowska, Wojciech Jacheć, Marzena Zalewska and Ewa Romuk
Medicina 2024, 60(5), 760; https://doi.org/10.3390/medicina60050760
Available online: https://www.mdpi.com/1648-9144/60/5/760
5. “Association between Statin Use and Chemotherapy-Induced Cardiotoxicity: A Meta-Analysis”
by Vikash Jaiswal, Song Peng Ang, Novonil Deb, Muhammad Hanif, Nitya Batra, Sai Gautham Kanagala, Nikhil Vojjala, Kripa Rajak, Poulami Roy, Medha Sharath et al.
Medicina 2024, 60(4), 580; https://doi.org/10.3390/medicina60040580
Available online: https://www.mdpi.com/1648-9144/60/4/580
6. “The Clinical Applications of Left Atrial Strain: A Comprehensive Review”
by Thomas O’Neill, Puneet Kang, Andreas Hagendorff and Bhupendar Tayal
Medicina 2024, 60(5), 693; https://doi.org/10.3390/medicina60050693
Available online: https://www.mdpi.com/1648-9144/60/5/693
7. “Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure”
by Mayu Yazaki, Takeru Nabeta, Yu Takigami, Yuko Eda, Teppei Fujita, Yuichiro Iida, Yuki Ikeda, Shunsuke Ishii and Junya Ako
Medicina 2024, 60(1), 84; https://doi.org/10.3390/medicina60010084
Available online: https://www.mdpi.com/1648-9144/60/1/84
8. “Current Opinion on Diagnosis of Peripheral Artery Disease in Diabetic Patients”
by Francesca Ghirardini and Romeo Martini
Medicina 2024, 60(7), 1179; https://doi.org/10.3390/medicina60071179
Available online: https://www.mdpi.com/1648-9144/60/7/1179
9. “High ADMA Is Associated with Worse Health Profile in Heart Failure Patients Hospitalized for Episodes of Acute Decompensation”
by Anamaria Vîlcea, Simona Maria Borta, Romana Olivia Popețiu, Rus Larisa Alexandra, Luminița Pilat, Dragoș Vasile Nica and Maria Pușchiță
Medicina 2024, 60(5), 813; https://doi.org/10.3390/medicina60050813
Available online: https://www.mdpi.com/1648-9144/60/5/813
10. “High-Intensity Interval Training vs. Medium-Intensity Continuous Training in Cardiac Rehabilitation Programs: A Narrative Review”
by Alexandru Dan Costache, Alexandra Mastaleru, Maria Magdalena Leon, Mihai Roca, Radu Sebastian Gavril, Diana Elena Cosău, Andreea Rotundu, Alice Ioana Amagdalinei, Ovidiu Mitu, Irina Iuliana Costache Enache et al.
Medicina 2024, 60(11); 1875; https://doi.org/10.3390/medicina60111875
Available online: https://www.mdpi.com/1648-9144/60/11/1875
Special Issues
Atrial Fibrillation and Heart Failure Management
https://www.mdpi.com/journal/medicina/special_issues/43X4IS0WCL
Guest Editor: Dr. Erika Bertella
Submission deadline: 30 September 2025
Clinical Updates and Future Perspectives on Acute Myocardial Infarction
https://www.mdpi.com/journal/medicina/special_issues/P1H7469844
Guest Editors: Dr. Ciro Mauro, Dr. Fulvio Cacciapuoti and Dr. Gerardo Carpinella
Submission deadline: 31 October 2025
Multimodal Imaging Techniques in Myocardial Ischemia: Current Applications and Future Prospects
https://www.mdpi.com/journal/medicina/special_issues/N36MCILPP1
Guest Editors: Dr. Fausto Pizzino and Dr. Giovanni Concistrè
Submission deadline: 30 October 2025
Aortic Stenosis: Diagnosis and Clinical Management
https://www.mdpi.com/journal/medicina/special_issues/SO80ESQXGX
Guest Editors: Dr. Tsung‐Ying Tsai and Dr. Ali Aldujeli
Submission deadline: 30 November 2025
1 May 2025
Medicina | Editor-in-Chief and Editorial Board Meeting Held on 2 April 2025
On 2nd April 2025, Medicina (ISSN: 1648-9144) held its Editorial Board meeting, chaired by Editor-in-Chief Prof. Dr. Edgaras Stankevičius. 7 Editorial Board Members and 2 JRSs attended this meeting. The meeting was organized on the occasion of Author Training—MDPI Open Science Insights: Scientific Publishing Exchange at the Lithuanian University of Health Sciences (LSMU) held on 3rd April 2025.
We are extremely grateful for the strong support of our Editorial Board Members and for the opportunity to have a face-to-face meeting to discuss the development of Medicina. We sincerely hope that more Editorial Board Members can attend future meetings.
The meeting began with a presentation including an introduction to Medicina, a summary of the Editorial Board Membership, journal statistics, and market activities.
The following topics were discussed:
- Quality of Submissions: How can this be improved?;
- Number of Submissions: How can we attract more high-quality papers?;
- Inactive EBMs: How can we activate them more?;
- New EBMs: Any recommendations?;
- Journal’s exposure and academic reputation: how to improve it?;
- Experience working with Medicina—Ideas and Suggestions.

Attendee list (in no particular order):
- Prof. Dr. Edgaras Stankevičius (Editor-in-Chief), Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania;
- Prof. Dr. Ričardas Radišauskas, Department of Environmental and Occupational Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, LT-47181 Kaunas, Lithuania;
- Prof. Dr. Vytenis Arvydas Skeberdis, Institute of Cardiology, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania;
- Prof. Dr. Vilmantė Borutaitė, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 4, LT-50162 Kaunas, Lithuania;
- Prof. Dr. Vita Mačiulskienė (Section Editor-in-Chief), Faculty of Odontology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania;
- Prof. Dr. Andrius Macas, Department of Anaesthesiology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania;
- Prof. Dr. Limas Kupčinskas, Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania;
- Prof. Dr. Vitalis Briedis, Department of Clinical Pharmacy, Faculty of Pharmacy, Academy of Medicine, Lithuanian University of Health Sciences, Sukilėlių av. 13, 50162 Kaunas, Lithuania;
- Dr. Jurgita Grigienė (EiC Assistant), Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania;
- Silvija Seles Gugolj, Journal Relations Specialist;
- Anna Krakowka, Journal Relations Specialist.
The latest official CiteScore (2023 Scopus data) for Medicina is 3.3, ranking Q1 in the “General Medicine” category. The current Impact Factor of Medicina is 4.1 (2023), ranking Q1 in the “Medicine, General, and Internal” category.
To access more journal statistics, please click here https://www.mdpi.com/journal/medicina/stats.
Medicina Editorial Office


















